第一作者单位:[1]Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
Li Y.,Chen Z.,Wu L.,et al.Novel tumour mutation score versus tumour mutation burden in predicting survival after immunotherapy in pan-cancer from MSK-IMPACT cohort[J].ANNALS OF ONCOLOGY.2019,30:
APA:
Li, Y.,Chen, Z.,Wu, L.&Tao, W..(2019).Novel tumour mutation score versus tumour mutation burden in predicting survival after immunotherapy in pan-cancer from MSK-IMPACT cohort.ANNALS OF ONCOLOGY,30,
MLA:
Li, Y.,et al."Novel tumour mutation score versus tumour mutation burden in predicting survival after immunotherapy in pan-cancer from MSK-IMPACT cohort".ANNALS OF ONCOLOGY 30.(2019)